1. High end-of-life incidence of seizures and status epilepticus in patients with primary and secondary brain tumors

   • Sophie von Brauchitsch
   • Adam Strzelczyk
   • Martin Voss

   Research Open access 03 November 2022 Pages: 277 - 284

   

2. Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis

   • Rachel Thommen
   • Syed Faraz Kazim
   • Christian A. Bowers

   Case Study 31 October 2022 Pages: 285 - 297

   

3. CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models

   • Clara Quijano-Rubio
   • Manuela Silginer
   • Michael Weller

   Research Open access 10 November 2022 Pages: 299 - 310

   

4. Diffusion tensor imaging changes in patients with glioma-associated seizures

   • Marius Marc-Daniel Mader
   • Daniel Deuter
   • Lasse Dührsen

   Case Study Open access 07 November 2022 Pages: 311 - 320

   

5. Does preoperative gamma knife treatment affect the result of microresection of vestibular schwannoma?

   • Bowen Huang
   • Yanming Ren
   • Yuekang Zhang

   Research 31 October 2022 Pages: 321 - 329

   

6. Is intraoperative MRI use in malignant brain tumor surgery a health care burden? A matched analysis of MarketScan Database

   • Mayur Sharma
   • Dengzhi Wang
   • Brian J. Williams

   Case Study 26 October 2022 Pages: 331 - 339

   

7. Letter to the Editor

   • Abigail Goodman
   • Jose Velazquez-Vega
   • Jeffrey Olson

   Correspondence 28 October 2022 Pages: 341 - 343

8. Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study

   • Ayesha S. Ali
   • Joseph Lombardo
   • Wenyin Shi

   Research 10 November 2022 Pages: 345 - 350

   

9. Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma

   • Pedro Iglesias
   • Betina Biagetti
   • Juan J. Díez

   Research 10 November 2022 Pages: 351 - 359

   

10. Moderately hypofractionated versus conventionally fractionated radiation therapy with temozolomide for young and fit patients with glioblastoma: an institutional experience and meta-analysis of literature

    • Phoebe Chidley
    • Mihir Shanker
    • Joseph Sia

    Research Open access 10 November 2022 Pages: 361 - 374

    

11. NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells

    • Shohei Tsuji
    • Shinsuke Nakamura
    • Hideaki Hara

    Research 29 October 2022 Pages: 375 - 388

    

12. Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?

    • Roberta Rudà
    • Francesco Bruno
    • Riccardo Soffietti

    Case Study 30 October 2022 Pages: 389 - 402

13. Seizures in patients with IDH-mutated lower grade gliomas

    • Louise Carstam
    • Isabelle Rydén
    • Asgeir Store Jakola

    Research Open access 18 October 2022 Pages: 403 - 411

    

14. Improving quality of life post-tumor craniotomy using personalized, parcel-guided TMS: safety and proof of concept

    • Si Jie Tang
    • Jonas Holle
    • Jacky Yeung

    Research 29 October 2022 Pages: 413 - 422

    

15. Brainstem tumors may increase the impairment of behavioral emotional cognition in children

    • Heyuan Jia
    • Peng Zhang
    • Liwei Zhang

    Research Open access 04 November 2022 Pages: 423 - 432

    

16. Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis

    • Jingjing Wang
    • Yan Huang
    • Xingchen Peng

    Research 10 November 2022 Pages: 433 - 443

    

17. What surgical approach for left-sided eloquent glioblastoma: biopsy, resection under general anesthesia or awake craniotomy?

    • Clémentine Gallet
    • Anne Clavreul
    • Jean-Michel Lemée

    Research 03 November 2022 Pages: 445 - 454

    

18. Comparison of surgery with or without adjuvant radiotherapy in treating central neurocytoma: a single-center retrospective real-world study

    • Lei She
    • Dongfeng Deng
    • Chao Liu

    Research 28 October 2022 Pages: 455 - 462

    

19. Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high-grade gliomas

    • Makoto Ohno
    • Shigehisa Kitano
    • Yoshitaka Narita

    Research 25 October 2022 Pages: 463 - 472

    

20. Ventricular entry during surgical resection is associated with intracranial leptomeningeal dissemination in glioblastoma patients

    • Francesca Battista
    • Giovanni Muscas
    • Alessandro Della Puppa

    Research Open access 23 October 2022 Pages: 473 - 480

    

21. Matched case–control analysis of outcomes following surgical resection of incidental meningioma

    • Silky Chotai
    • Alan R. Tang
    • Lola B. Chambless

    Research 03 November 2022 Pages: 481 - 489

    

22. Prognostic implication of size on outcomes of pituitary macroadenoma: a comparative analysis of giant adenoma with non-giant macroadenoma

    • Muhammad Faraz Raghib
    • Adnan Salim
    • Syed Ather Enam

    Research 31 October 2022 Pages: 491 - 496

23. Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis

    • Lingcheng Zeng
    • Hua Li
    • Jiasheng Yu

    Case Study 02 November 2022 Pages: 497 - 504

    

24. Radiotherapy for meningiomas

    • William C. Chen
    • Haley K. Perlow
    • David R. Raleigh

    Review Open access 31 October 2022 Pages: 505 - 515

    

25. Patient satisfaction and cost savings analysis of the telemedicine program within a neuro-oncology department

    • James K. C. Liu
    • Richard Kang
    • Michael A. Vogelbaum

    Research 11 November 2022 Pages: 517 - 525

    

26. Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis

    • Mason Webb
    • Derek R. Johnson
    • Ugur Sener

    Research 27 October 2022 Pages: 527 - 534